financetom
NARI
financetom
/
Healthcare
/
NARI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Inari Medical, Inc.NARI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States.

The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases.

It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.

Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Latest News >
Update: Generation Mining Applauds International Energy Forum Report Outlining EV Copper Hurdles
Update: Generation Mining Applauds International Energy Forum Report Outlining EV Copper Hurdles
Jun 3, 2024
07:37 AM EDT, 06/03/2024 (MT Newswires) -- Generation Mining ( GENMF ) on Monday cheered a recent report by the International Energy Forum outlining rising global demand for copper amid the energy transition. The report, titled Copper Mining and Vehicle Electrification, found that the world will not be able to produce enough copper to transition to 100% electric vehicle production...
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
Jun 3, 2024
07:40 AM EDT, 06/03/2024 (MT Newswires) -- Science Applications International ( SAIC ) reported fiscal Q1 adjusted earnings Monday of $1.92 per diluted share, down from $2.14 a year earlier. Analysts polled by Capital IQ expected $1.92. Revenue for the fiscal quarter ended May 3 was $1.85 billion, down from $2.03 billion a year earlier. Analysts surveyed by Capital IQ...
Structure Therapeutics' obesity drug meets main goal in mid-stage study
Structure Therapeutics' obesity drug meets main goal in mid-stage study
Jun 3, 2024
June 3 (Reuters) - Structure Therapeutics ( GPCR ) said on Monday its obesity drug candidate met the main goal in a mid-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Devika Syamnath) ...
Market Chatter: Blackstone Considering Sale of Alinamin Pharmaceutical
Market Chatter: Blackstone Considering Sale of Alinamin Pharmaceutical
Jun 3, 2024
07:32 AM EDT, 06/03/2024 (MT Newswires) -- Blackstone (BX) is exploring the sale of Alinamin Pharmaceutical Co., a Japanese consumer healthcare firm previously owned by Takeda Pharmaceutical Co. for around 300 billion yen ($1.9 billion), Bloomberg reported on Monday, citing people familiar with the situation. Interest in Alinamin has been expressed by investment firms such as CVC Capital Partners Plc,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved